Kimberley T Lee, MD, MHS
CPUP Presidential Assistant Professor
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
10 South Pavilion
Philadelphia, PA 19104
3400 Civic Center Blvd
10 South Pavilion
Philadelphia, PA 19104
Education:
BS (Biological Sciences )
Florida International University , 2010.
MD (Medicine )
Johns Hopkins University , 2014.
MHS (General Epidemiology )
Johns Hopkins University, 2020.
Permanent linkBS (Biological Sciences )
Florida International University , 2010.
MD (Medicine )
Johns Hopkins University , 2014.
MHS (General Epidemiology )
Johns Hopkins University, 2020.
Description of Clinical Expertise
Dr. Lee is an award-winning physician-scientist who specializes in breast cancer care and is nationally recognized for her work in advancing equity in health care. In her clinical practice, she supports individuals and families facing breast cancer with compassion, precision, and the latest treatment strategies.Description of Research Expertise
Dr. Lee's research focus lies at the intersection of epidemiology, health services research, and implementation science, where she investigates modifiable biological, clinical, and health care-related factors that contribute to disparities in breast cancer survival. She leverages her expertise in analyzing large-scale databases to gain deeper insights into disparities in cancer care delivery. Furthermore, she conducts mixed methods research to intimately understand the intricate interplay of patient and provider factors that influence breast cancer care. She ultimately aims to develop and test interventions to address barriers to equitable care, working towards improved outcomes for women with breast cancer. With numerous publications in national and international medical journals and recognition from peers and professional organizations, Dr. Lee brings both scientific rigor and human-centered care to everything she does. She is passionate about turning research into real-world solutions that improve lives, reduce inequities, and build a more just health care system.Selected Publications
Lee KT, Hu B, Martinez Tyson D, Geiss C, Vadaparampil ST, Jim HSL, Gwede CK, Soliman HH, Henry NL, Hershman DL. : A mixed-methods study characterizing experiences of medical oncologists' use of gonadotropin-releasing hormone agonists for treatment of breast cancer. Breast Cancer Res Treat. 212(3), Aug 2025.Lee KT, Geiss C, Fulton HJ, Charles D, Gonzalez BD, Jim HSL, Henry NL, Hershman DL, Tworoger SS, Bradbury A, Fayanju OM, Vadaparampil ST, Gwede CK. : Hidden Costs of Endocrine Therapy for Black Breast Cancer Survivors: A Qualitative Examination of Patient and Provider Experiences. Clin Breast Cancer. July 2025.
Ahmed KA, Kim Y, Armaghani AJ, Arrington JA, Costa RL, Czerniecki BJ, Diaz R, Dowell RA, Extermann M, Forsyth PA, Lee KT, Loftus L, Mills MN, Phuoc VH, Rosa M, Soliman HH, Sam CS, Washington IR, Soyano AE, Han HS. : Phase II trial of brain MRI surveillance in stage IV breast cancer. Neuro Oncol. 30(27): 1550-1558, July 2025.
Lee KT, Maconi M, Geiss C, Jim HSL, Gwede CK, Soliman HH, Vadaparampil S: Decision-making and Understanding of Ovarian Function Suppression Treatments Amongst Survivors of HR+ Breast Cancer. Society of Behavioral Medicine 46th Annual Meeting, San Francisco, CA. 2025.
Kimberley T. Lee, Brian Egleston, Sarah Brown, Sarah Howe, Dominique Fetzer, Lauren Gutstein, Cara Cacioppo, Dana Clark, Susan Domchek, Jessica Ebrahimzadeh, Dana Falcone, Demetrios Ofidis, Hannah Griffin, Rajia Mim, Santina Hernandez, Linda Fleisher, Kelsey Karpink, Enida Selmani, Aysha Tahsin, Lynne Wagner, Michelle Weinberg, Kuang Yi-Wen, Elisabeth Wood, Angela R. Bradbury. : The eREACH Study: A Randomized Study of an eHEALTH Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients with Metastatic Cancers. JMIR Res Protoc (forthcoming) 2025.
Lee KT, Hu E, Henry NL, Hershman D, Hoogland AI, Gwede CK, Jim HSL, Soliman HH, Vadaparampil ST.: Exploring Oncologists’ Experiences with Ovarian Function Suppression for Breast Cancer. American Society of Preventive Oncology, Annual Meeting. 2025.
Angela R. Bradbury, Brian L. Egleston, Sarah Brown, Briana Mcleod, Dominique Fetzer, Cara Cacioppo, Janice Christiansen, Dana Farengo-Clark, Susan M. Domchek, Jessica E. Ebrahimzadeh, Linda Fleisher, Sarah Howe, Kelsey Karpink, Kimberley T. Lee, Enida F. Selmani, Lynne I. Wagner, Michelle Weinberg, Kuang-Yi Wen, Elisabeth Wood, Penn Telegenetics Program. : The eREACH study: A randomized study of an eHEALTH delivery alternative for cancer genetic testing for hereditary predisposition in patients with metastatic cancers. J Clin Oncol 43(16_suppl): 10502, 2025 Notes: Oral presentation.
Geiss C, Blackwell RM, Maconi ML, Buhlmann M, Welniak T, Lee KT, Kirtane K, Gonzalez BD. : Assessing feasibility, appropriateness, and acceptability of digital patient journaling for qualitative data collection in cancer research. 46th Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine 2025.
Lee KT, Bulls HW, Hoogland AI, James BW, Colon-Echevarria CB, Jim HSL.: A Narrative Review and Proposed Theoretical Model. Cancers (Basel). 16(14), July 2024.
Lee KT, Gonzalez BD, Geiss C, Fulton HJ, Charles D, Vadaparampil, ST, Henry NL, Jim, HSL, Hershman, DL, Tworoger S, Gwede CK. : Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers. J Cancer Surviv Mar 2024.